Stay updated on BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedThe study record for BMS-986249 with or without nivolumab in advanced solid tumors is available, with trial details and results-related information, study documents, and links.SummaryDifference96%

- Check14 days agoChange DetectedThe footer revision identifier was updated from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check28 days agoChange DetectedA general NIH website-transition notice was added above the ClinicalTrials.gov 403 error page. The footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check42 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the usual study record content with a standard error screen. This indicates access is blocked rather than updated information for the study.SummaryDifference21%

- Check63 days agoChange DetectedThe page revision label was updated from v3.6.6 to v3.7.0, indicating a new version of the page has been published.SummaryDifference0.0%

Stay in the know with updates to BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page.